Ginkgo BioworksDNA

紐約證券 · USD
7.71
+1.18
(+18.07%)
收盤 08/20 03:59 (UTC+8)
盤後 
7.71 
7.71 
(0.00%)
08/20 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.38
  • 0.56
  • 0.89
  • 0.44
  • 0.48
  • 0.60
  • 0.59
  • 0.33
  • 0.19
  • 0.20
icon
  • 9.18
  • 48.13
  • 58.43
  • -50.76
  • 10.20
  • 23.54
  • -0.50
  • -14.01
  • -41.69
  • 3.50
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
20,156
19,474
33,396
59,395
59,692
48,318
43,847
89,046
56,206
37,944
營業成本
1,7193,0987,30130,20122,77912,0479,62212,00313,7219,202
營業毛利
18,437
16,376
26,095
29,194
36,913
36,271
34,225
77,043
42,485
28,742
營業費用
76,98587,75096,847134,585110,450125,239----
研發費用
46,21049,92050,12769,35353,37070,92376,37777,006134,221136,457
推銷及管理費用
30,77537,83046,01462,57252,59949,04357,29752,29266,28570,287
非經常性項目費用
--7062,6604,4815,2734,1572,94964,924-
其他營業費用
----------
營業利益
-58,548
-71,374
-70,046
-105,391
-73,537
-88,968
-103,606
-55,204
-222,945
-178,002
其他收入及費用
6,028-4,765-10,6429,8845,307-1,901-4,159-1,5745,95412,122
利息費用
------94---
稅前純益
-57,193
-76,139
-81,394
-95,507
-68,230
-90,869
-107,859
-56,778
-216,991
-165,880
所得稅
128-80-6431-28388-325-37519031
稅後純益
-46,710
-82,587
-80,751
-80,755
-60,300
-90,957
-107,534
-56,403
-217,181
-165,911
基本每股稅後盈餘(元)
-0.75-1.39-1.41-1.45-1.10-1.68-2.00-1.08-0.11-0.08
稀釋每股稅後盈餘(元)
-2.13-1.39-1.42-1.45-2.77-1.68-1.96-1.02-0.11-0.08
基本平均股數(千股)
62094.0059563.0057098.0055633.0054858.0054241.0053814.0052240.002054801.002004458.00
稀釋平均股數(千股)
62094.0059563.0057098.0055633.0054858.0054241.0053814.0052246.002055023.002005334.00
還原基本每股稅後盈餘(元)
-0.75-1.39-1.41-1.45-1.10-1.68-2.00-1.08-4.23-3.31
還原稀釋每股稅後盈餘(元)
-2.13-1.39-1.42-1.45-2.77-1.68-1.96-1.02-4.24-3.32
還原基本平均股數(千股)
62,09459,56357,09855,63354,85854,24153,81452,24051,37050,111
還原稀釋平均股數(千股)
62,09459,56357,09855,63354,85854,24153,81452,24651,37550,133
EBITDA(千元)
-34,238-69,988-68,619-68,000-44,246-75,503-92,113-39,609-199,661-153,011

大家都在看

HOT